The bill amends section 499.0295 of the Florida Statutes to provide an exemption from public records requirements for certain information in a public report published by the Department of Health regarding experimental treatment outcomes and safety signals. Specifically, it states that the health information and proprietary pricing information contained in this report is confidential and exempt from public disclosure under s. 119.07(1) and s. 24(a), Article I of the State Constitution. This change aims to protect sensitive personal health data of patients with terminal conditions or life-threatening rare diseases.

Additionally, the bill includes a statement of public necessity, asserting that the confidentiality of this information is crucial to prevent potential harm to patients. It emphasizes that patients pursuing experimental treatments have a strong expectation of privacy regarding their medical information, and the risks associated with disclosing such information outweigh any public benefits that might arise from its release. The act is set to take effect contingent upon the adoption of HB 1381 or similar legislation in the same legislative session.